US Patent Issued to Cartesian Therapeutics on Dec. 30 for "Methods related to administering immunosuppressants and non-allergenic antigens to reduce or prevent anaphylaxis" (California Inventor)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,249, issued on Dec. 30, was assigned to Cartesian Therapeutics Inc. (Watertown, Mass.).

"Methods related to administering immunosuppressants and non-allergenic antigens to reduce or prevent anaphylaxis" was invented by Roberto A. Maldonado (Berkeley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to methods for reducing or preventing anaphylaxis to non-allergenic antigens with compositions comprising immunosuppressants, and related compositions."

The patent was filed on April 24, 2020, under Application No. 16/858,349.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/...